Skip to content
Wednesday 26 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,878.12
-0.07%
DAX
26,285.96
+0.08%
CAC 40
8,462.39
+0.27%
STOXX 50
6,470.74
+0.23%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • Staples Vegetables Announces Strategic Partnership with Solum Partners

    November 18, 2025

    Leading UK food and renewable-energy producer joins forces with global agribusiness investment firm to fuel growth, innovation, and sustainability initiatives.

  • NIQ Launches New Brand Traction Score Designed to Reveal How Effectively FMCG Brands Convert Shelf Presence Into Real Consumer Purchases

    November 18, 2025

    Coca-Cola, Philadelphia and Nutella rank highest among the top 15 FMCG brands that have the highest traction score in Western Europe The higher the score, the more effectively a brand not only reaches consumers but also converts visibility into sales NIQ also highlights a growing trend across Europe, where rising brand traction scores are closely aligned with the strongest sales growth

  • Artec 3D Launches Artec Studio Lite: Professional 3D Capture for Everyone

    November 18, 2025

    Global 3D scanning leader Artec 3D has launched a new, accessible version of its software, Artec Studio Lite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118804372/en/ Designed to make Artec Studio’s professional 3D tools available to a larger audience, Artec Studio Lite pairs cutting-edge AI Photogrammetry with advanced 3D processing and analysis, [...]

  • ShipStation® Improves Fulfilment Efficiency for UK Businesses With Enhanced Platform Capabilities

    November 18, 2025

    UK merchants can now seamlessly manage shipping operations with new inventory and analytics solutions, flexible plans including a free option, and product advancements

  • European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab

    November 18, 2025

    Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3

  • Finimize and Charles Schwab to Deliver Educational Investment Content to International Investors

    November 18, 2025

    Multi-channel campaign will provide customised educational guides and webinars for retail investors

  • Beyond by RS2 Becomes a Principal Issuing Member of Visa

    November 18, 2025

    Beyond by RS2, the innovation brand of RS2 Financial Services GmbH, has become a Principal Issuing Member of Visa in Europe – allowing the company to directly issue Visa cards and to launch and manage payment card programs. With this milestone, Beyond by RS2 strengthens its position as an end-to-end payment partner, combining issuing, acquiring, [...]

  • Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg

    November 18, 2025

    Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence

  • Gary Haase to Join Everest as EVP, CEO of Legacy Operations

    November 17, 2025

    Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, today announced the appointment of Gary Haase as Executive Vice President and CEO of Legacy Operations, effective December 1, 2025. He will report to Jim Williamson, Everest’s President and CEO, and will join the Company’s Executive Leadership Team. The [...]

  • Dilawer Farazi Returns to Loomis Sayles as Co-Head and Portfolio Manager on the Emerging Markets Debt Team

    November 17, 2025

    Loomis, Sayles & Company is pleased to announce that Dilawer Farazi, ACA, has rejoined the firm as Co-Head and Portfolio Manager of the Emerging Markets Debt (EMD) Team. Dilawer becomes the firm’s first London-based portfolio manager. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117681347/en/ Dilawer brings over two decades of experience in [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • …
  • Page 228
  • Next

Trending Articles

  • Andy Burnham hints at tax rises in Autumn Budget

  • Pensioners to hand over bank statements in government benefits crackdown

  • Budget 2026: Which taxes will Burnham and Healey hike?

  • Burnham shelves Thames Water administration plans over costs

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook